Cardiovascular event reduction with PCSK9 inhibition among 1578 patients with familial hypercholesterolemia results from the SPIRE randomized trials of bococizumab

Paul M. Ridker Raul Dias dos Santos Filho; Lynda M Rose; John J. P Kastelein; Caimiao Wei; James Revkin; Carla YUNIS; Jean-Claude Tardif; Charles L Shear

Journal of clinical lipidology v. 12, n. 4, p. 958-965, 2018

New York 2018

Localização: FM - Fac. Medicina    (OPI 29397 2018 )(Acessar)